Mraz Amerine & Associates Inc. Boosts Position in CVS Health Co. (NYSE:CVS)

Mraz Amerine & Associates Inc. raised its position in shares of CVS Health Co. (NYSE:CVS) by 10.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 20,643 shares of the pharmacy operator’s stock after purchasing an additional 2,022 shares during the quarter. Mraz Amerine & Associates Inc.’s holdings in CVS Health were worth $1,298,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Livelsberger Financial Advisory bought a new position in CVS Health in the 3rd quarter worth $31,000. First Community Trust NA raised its stake in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 302 shares during the period. Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health during the 3rd quarter valued at about $33,000. ORG Partners LLC grew its stake in shares of CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 592 shares during the period. Finally, Oliver Lagore Vanvalin Investment Group increased its holdings in CVS Health by 71.0% in the 2nd quarter. Oliver Lagore Vanvalin Investment Group now owns 595 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 247 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

Shares of CVS Health stock opened at $56.11 on Friday. The stock has a market cap of $70.44 billion, a price-to-earnings ratio of 9.86, a price-to-earnings-growth ratio of 0.93 and a beta of 0.54. The stock has a 50 day moving average price of $59.88 and a 200-day moving average price of $60.17. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. During the same quarter in the previous year, the business posted $2.21 earnings per share. The business’s revenue was up 2.6% compared to the same quarter last year. Equities analysts expect that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be paid a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.74%. CVS Health’s dividend payout ratio is 46.75%.

Analyst Ratings Changes

Several equities analysts have weighed in on CVS shares. Evercore ISI lifted their price target on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Truist Financial upped their target price on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a report on Friday, October 11th. Wells Fargo & Company upped their price objective on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. Royal Bank of Canada reissued an “outperform” rating and set a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $74.58.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.